Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Probi initiates partnership with Clasado for the development of synbiotics

Probi has entered into a partnership with Clasado Biosciences ("Clasado"), a company renowned for its research and development of prebiotics and the multi-award-winning ingredient Bimuno[®] GOS. Clasado is a company renowned for its research in prebiotics, and their prebiotic product Bimuno[®] GOS holds a leading market position and is one of the most clinically studied prebiotic ingredients with over 20 clinical trials. The purpose of this partnership is to leverage Probi's and Clasado's market-leading and scientific portfolios in probiotics and prebiotics, respectively, to develop

Bulletin from the Extraordinary General Meeting on Thursday 8 June in Clinical Laserthermia Systems AB

Today, June 8, 2023, an Extraordinary General Meeting was held in Clinical Laserthermia Systems AB, org. no. 556705–8903. Below is a summary of the decisions taken. All decisions were taken with the required majority.Resolution to amend the Articles of Association The Extraordinary General Meeting resolved to amend the Articles of Association in accordance with the following alternatives, and to authorize the Board of Directors to register the Articles of Association that are best suited based on the outcome of the Board's proposal for a resolution on a rights issue. Option 1*Please

S&P affirms Storskogen’s credit rating

On June 8, S&P Global Ratings (“S&P”) affirmed Storskogen Group AB’s (“Storskogen”) credit rating (corporate family rating) of BB with a negative outlook. “In recent quarters, we have taken several measures that strengthen the credit quality of Storskogen. Among other things, we have extended our bank facilities, reduced our net debt, improved profitability year-over-year as well as clearly focused on and improved our cash flow. In addition, we have announced a number of divestments that will increase profitability and reduce net debt. As announced today, our next step is to well in

Bawat reaches financing agreement with Nefco to scale up its ballast water management system business

Ballast water discharged from shipping poses a serious environmental and economic threat due to the spreading of invasive species. With Nefco financing, Bawat will scale up its patented ballast water treatment system to reduce the environmental impact of shipping. Nefco – The Nordic Green Bank – has signed a loan agreement with Bawat , a Nordic company providing an environmentally friendly solution for ballast water treatment. Bawat’s system uses heat to pasteurise ballast water, making it a simple, cost-efficient, flexible and sustainable solution that requires

Peptonic wins arbitration case in China

Peptonic Medical AB (publ) today announced that an arbitration court in China has ruled in favor of Peptonic in a dispute with Yuanjia Biotechnology Co., Ltd.In November 2020 and February 2021, Peptonic Medical shipped goods to Yuanjia Bio in China for a total value of 406,000 EUR (approx. 4.4 MSEK). However, the goods were never paid for. As a result, Peptonic terminated the distribution agreement with Yuanjia Bio in August 2021 and filed an arbitration application against its former partner at a Chinese court. The court has now ruled in favor of Peptonic Medical and ordered Yuanjia Bio to

Veidekke: New residential project in Bjørvika

Oslo S Utvikling (OSU) has awarded Veidekke the commission to build the environmentally certified residential project Vannkunsten Syd in Bjørvika in Oslo. The contract is a design and build contract valued at NOK 476 million excluding VAT.Vannkunsten Syd consists of five separate buildings with a total of 91 apartments. Overall, the project is 15,500 m[2] in size, of which 12,400 m[2] are homes with underground parking and 3,100 m[2] commercial areas. The project will be certified in accordance with the BREEAM NOR environmental standard. “We would like to thank OSU for their confidence

Alvheim FPSO celebrates fifteen years of production

Today the Alvheim FPSO celebrates fifteen years of oil and gas production. The field and the production vessel have over-performed since production commenced on 8 June 2008. Perhaps the best birthday present comes from the Minister of Petroleum and Energy, Terje Aasland, who today granted approval for the development of Tyrving, which will be a tie-in to Alvheim. · Link to the Tyrving PDO approval press release  Alvheim FPSO. Aker BP is the operator for the Alvheim area. The Alvheim field is one of the most successful developments on the

Neurotech company Mentalytics secures SEK 4,4M investment through value-adding investors

Mentalytics, the Stockholm-based neurotech pioneers, secures a total investment of SEK 4,4M in preparation for a huge growth spurt with the launch of their new productline directed towards improving performance in manufacturing. Launched in 2003, Mentalytics has been at the forefront of commercial neurotech for as long as the industry has been around. Their flagship product, Mindball, has been sold to science centers across the entire globe. After a long-awaited pivot towards software, and a couple of years of development, the company is now ready to take on the challenges of

Approved development plan for Tyrving

Aker BP (OSE:AKRBP, OTCQX:AKRBF) The Norwegian Ministry of Petroleum and Energy has today approved the Plan for development and operation (PDO) for Tyrving (previously Trell & Trine) in the Alvheim area. The Operator Aker BP and licence partners Petoro AS and PGNiG Ustream Norway AS submitted the PDO to the Ministry in August last year (Link to the press release) . The Tyrving development will utilise the planned extended lifetime for the Alvheim field, increase production and reduce both

2.2 million passengers traveled with SAS during May

2.2 million passengers traveled with SAS in May, an increase by 19 percent compared to the same period last year. SAS’ capacity increased 17 percent and RPK increased by 26 percent, compared to the same period last year. The flown load factor for May was 77 percent, an improvement by almost 6 percentage points compared to May last year.   “We are pleased to see that the demand for travel continues to increase. 2.2 million passengers traveled with SAS in May, up 19 percent compared to the same month last year. We have ramped up to meet the increased demand for the summer season, and we

Final result of DNV’s Voluntary Recommended Public Cash Tender Offer for all Shares and Stock Options in Nixu: DNV Completes the Tender Offer

Nixu Corporation, Stock Exchange Release, June 8, 2023, 12.00 p.m. EETNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH THIS TENDER OFFER WOULD BE PROHIBITED BY APPLICABLE LAW. The global quality assurance and risk management provider DNV AS (“DNV” or the “Offeror”) has on February 28, 2023, commenced a voluntary recommended public cash tender offer for all the issued and outstanding shares (the “Shares” or, individually, a “Share”)

Metsä Board Corporation: Managers’ transactions (Joukio, Mika)

Metsä Board Corporation Stock exchange release Managers’ transactions 8 June 2023 at 12.00 noon EESTCEO of Metsä Board Corporation Mika Joukio has on 6 June 2023 disposed in total 121,903 company’s B shares. Metsä Board Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Mika Joukio Position: Chief Executive Officer  Issuer: Metsä Board Oyj LEI: 743700KKB8Q035K38488 Notification type: INITIAL NOTIFICATION Reference number: 33064/4/4 ____________________________________________

Zerion Pharma’s Dispersome® technology published in two peer-reviewed papers through partnerships with pharmaceutical companies

June 8, 2023 (COPENHAGEN, Denmark). Zerion Pharma A/S (“ZERION”) today announces the publication of joint experimental work on its Dispersome[®] technology in the International Journal of Pharmaceutics and Pharmaceutical Research, two peer-reviewed papers.The work behind the publications originated from two partnership projects, one with Bayer AG and one with Novartis Pharma AG. The former can be accessed here  and showcases the interplay between drug loading and dissolution performance in Dispersome[®] formulations on the drug Nimodipine. The

BioStock: Positive uTREAT-results in glioblastoma for Curasight

Biotech company Curasight recently revealed preclinical data demonstrating the effectiveness of uTREAT in treating glioblastoma. This discovery marks a significant step in the development of uTREAT as a new brain cancer therapeutics. BioStock contacted CEO Ulrich Krasilnikoff to learn more about what this milestone means for the company.Read the full article at biostock.se: https://www.biostock.se/en/2023/06/positive-utreat-results-in-glioblastoma-for-curasight/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

New date for the release of Interim report January – June 2023

The date for the release of Cabonline Group Holding AB (publ) Interim report January – June 2023 has been changed from Monday, 21 August to Thursday, 31 August 2023. For further information, please contact:Fredrik Lundqvist, CFO, +46 70 552 80 25, fredrik.lundqvist@cabonline.com About Cabonline Group:Cabonline is the leading taxi company in the Nordic region with, ~2,600 connected transporters and ~4,900 vehicles in Sweden, Norway, Finland and Denmark. Cabonline operates a series of well-known brands, such as Flygtaxi, TaxiKurir, Norgestaxi, TOPCAB, Kovanen, Taxi Skåne, Taxi Väst,

SEB’s The Green Bond report: The carbon removal issue

In the latest issue of SEB’s The Green Bond report, our experts conclude that the investment gap between clean and fossil energy is widening while the electrification of energy users is spreading, supporting their expectation that world fossil fuel consumption will peak in 2023. That puts international climate targets within reach, though carbon removal is now unavoidable to limit global warming to below 2 degrees according to the IPCC. The report contains contributions from leaders in the nascent market for carbon removals used to meet corporate net-zero targets. China still has a firm

Prevas acquires cutting-edge company in Life Science

Prevas has agreed on an organizational transition for staff and current assignments at SDS MedteQ. The organization will be migrated to Prevas in June 2023. Since its founding in 2020, SDS MedteQ has provided premium regulatory services and consulting to medtech companies around the world.PPP[An image showing human face, clothing, person, smiling, automatically generated description] Caption: Johan Sköld and Anna-Karin Alm from SDS MedteQ. Rapid development in medical technology and in the pharmaceutical industry, the increased digitalization of healthcare and preventive care in

Sensys Gatso Australia receives TRaffic enforcement as a Service (TRaaS) order for expansion of services in Tasmania to the value of SEK 26 million

Sensys Gatso Group, a global leader in traffic safety solutions, through its subsidiary Sensys Gatso Australia, has received multiple orders for the provision of additional Speed Enforcement and Distracted Driver Enforcement services as part of the Automated Traffic Offence Enforcement (ATOE) Program in the State of Tasmania. The orders are for a 2 year period and the combined contract value is AUD 3.6 million corresponding to approximately SEK 26 million.The orders are for the expansion of the existing ATOE Program which is delivered as a subscription service covering Managed Services and

Advania Group launches sustainability report

For the first time Advania Group is launching a Group-wide sustainability report covering all countries and recent acquisitions up until 2022. The report describes Advania’s common strategy for sustainability and how each country has committed to achieving ambitious joint targets.As one of the leading IT service providers in northern Europe, Advania Group makes a key contribution to sustainable development. The Group has clear objectives in this domain regarding its own organisation’s working methods, as well as those employed throughout the supply chain. As the pace of digitalisation

Kanthal presents the road towards fossil fuel-free heating processes at Thermprocess

How can electric heating decarbonize industrial heat treatment processes? At Thermprocess – the world’s biggest exhibition for innovative technologies for industrial thermoprocessing plants – Kanthal will showcase electric heating as a viable solution that industries can benefit from already today.From steel and aluminum to semiconductors and glass, many of the world’s industrial manufacturers are facing the challenges of reducing their CO2 emissions.   “In many industrial processes, electric heating can play a significant role when it comes to carbon reductions. By replacing

Preferential share issue registered and trade with paid subscribed shares ceases

Prostatype Genomics AB ("Prostatype Genomics" or the "Company") has performed a preferential share issue of shares which was finalized on 11 May 2023. The preferential share issue has now been registered with the Swedish Companies Registration Office and the last day for trading with paid subscribed shares (Sw. BTA) is on 12 June 2023. The record date is 14 June 2023, after which paid subscribed shares are transformed to shares as per 16 June 2023.For further information about Prostatype Genomics, please contact: Nicklas Rosendal, Press ContactPhone: +46 708-89 33 34E-mail: nicklas.

iCellate Medical secures 20 MSEK in new funding

Stockholm, Sweden – June 8, 2023 - iCellate Medical has closed a successful round of financing, raising 20 MSEK from a combination of existing and new investors. iCellate develops cancer tests for early detection, treatment selection, and hereditary cancer risk.iCellate is a privately held life sciences company, spearheading the industry in cancer profiling. Through liquid biopsy tests, the analysis of tumor-derived material in the blood or saliva, iCellate paves the way for precision medicine to reach more patients. Ongoing clinical studies investigating iCellate’s CTC-based technology,

Risk Intelligence A/S and an internationally operating Malaysian Energy Infrastructure Company sign a deal for the Risk Intelligence System and security consultancy

Risk Intelligence A/S and an internationally operating Malaysian Energy Infrastructure Company sign a deal for the Risk Intelligence System and security consultancy support to future operations.The agreement will provide the Malaysian client with enhanced situational awareness as their operations expand. The client already has operations in in South-east Asia, South America and West Africa. Advisory Services, the Risk Intelligence consultancy arm, will be supporting their energy projects through bespoke security and voyage risk assessments, as well as via Risk Intelligence’s cloud-based

There are no items matching the current filter
There are no more items matching the current filter
Back to top